Tirzepatide is an innovative dual-action medication that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-receptors. Manufactured under stringent Good Manufacturing Practices (GMP) with Drug Master File (DMF) support, Tirzepatide stands out as a first-in-class therapy. This groundbreaking treatment offers unparalleled efficacy in managing blood sugar levels and promotes effective weight loss by leveraging its unique dual mechanism of action. Discover how Tirzepatide can transform diabetes and obesity management for better health outcomes